共 50 条
- [32] The effect of infliximab plus methotrexate therapy on the modulation of inflammatory disease markers in patients with juvenile rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S86 - S86
- [33] EVALUATION OF RESPONSE TO METHOTREXATE BY A FUNCTIONAL INDEX IN CHILDREN WITH JUVENILE RHEUMATOID-ARTHRITIS [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S123 - S123
- [35] Methotrexate polyglutamate concentrations in red blood cells correlates with disease activity and clinical response to methotrexate in rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S135 - S135
- [36] Evaluation of nabumetone (Relafin®) in patients with juvenile rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S291 - S291
- [37] Predictors of school attendance of children with juvenile rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 529 - 529
- [38] Methotrexate in juvenile idiopathic arthritis. Adverse effects and associated factors [J]. ANALES DE PEDIATRIA, 2020, 92 (03): : 124 - 131
- [39] The role of neuroencocrine immune system in juvenile rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4088 - 4088
- [40] T regulatory cell dysfunction in juvenile rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S693 - S693